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Introduction
This is a brief progress report on research on the molecular
and biochemical characteristics of the bone morphogenetic
proteins (BMP) in rat cortical bone matrix. The BMP
guides modulation and differentiation of mesenchymal
cells of muscle into bone and bone marrow cells. Previous
communications deal with the histophysiology of the
response of several vertebrate species to the BMP, and are
concerned with temporal, spatial, and biologic features of
the bone morphogenetic process in the living animal [1–14]
and in systems in vitro [15, 16]. In the rodent, bioassay of
BMP is made by implantation of a known weight of
lyophilized bone matrix in muscle, fascia, or subcutaneous
tissue [10]. Since the matrix demineralized in vitro does
not recalcify, bone tissue produced by a given quantity of
old matrix including BMP can be determined by measuring
the ash weight per gram of dry weight of preimplanted
matrix. The basis of the quantitative biochemical rela-
tionships between BMP in bone matrix and the yield of
new bone is an embryonic induction system for
osteogenesis in postfetal life. Little is known about the
genetic control mechanism of bone cell differentiation.
Terminology and theoretical concepts now being used are
deﬁned in the appendix, pages 1403–1404.
Preparations of Demineralized Matrix Producing Low
Incidence and Yields of New Bone
Demineralized matrix of bones and teeth, as prepared by
several research groups, has been reported to produce
bone in rodents. Rat dentin matrix prepared by Huggins,
Wiseman, and Reddi [17], and rabbit bone matrix prepared
by Nade [18] produced bone in a signiﬁcant number
of implants. Preparations similar to those of Huggins,
Wiseman, and Reddi and Nade tested by our research
group produced bone, but the yield was relatively low, and
at least half of the implants produced only ﬁbrous tissue.
Some demineralization procedures reduce the yield of new
bone more than others [1]. Huggins, Wiseman, and Reddi
[17], made coarse powders of dentin, and demineralized
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hours. The powdered matrix was extracted with ethanol
and sterilized in water-saturated phenol for 30 minutes.
The sterile matrix was then washed in 70% ethanol in
water, frozen in liquid nitrogen, dehydrated in ethanol and
ether, dried overnight at 37 C, and sieved to a standard
particle size. After extraction and denaturation of tissue
proteins in this series of solutions, rat dentin matrix was
implanted in xenogeneic guinea pigs and mice with little or
no histoincompatibility reaction.
The unique physicochemical properties of dentin matrix
must be taken into consideration in interpreting the
observations of Huggins, Wiseman, and Reddi [17]. Dentin
collagen is more highly cross-linked than bone collagen
and more resistant to denaturation [19]. The highly cross-
linked structure of dentin matrix is also more resistant than
bone matrix to chemical and thermal denaturation, partic-
ularly if it is undemineralized when subjected to the heat of
pulverization. When bone matrix is demineralized ﬁrst and
then ground to a particle size of a diameter less than 400
micrometers (lm) the protein structure is denatured sufﬁ-
ciently to eliminate all morphogenetic activity [20]. These
observations suggest that the mineral protects the BMP
from thermal denaturation. The mineral also insulates the
BMP and prevents transmission of the morphogenetic
property from bone matrix to proliferating mesenchymal
cells [8].
Differences among species are notable in both respon-
siveness of allogeneic recipients to the BMP, and potency
of BMP in xenogeneic recipients. Urist and Craven [9]
noted that the stability of the BMP as determined from
yield of bone in various species was as follows: rabbit >
rat > guinea pig > mouse > , etc. Huggins, Wiseman, and
Reddi [17], observed that the rat was the more responsive
and produced bone in implants of allogeneic matrix and in
implants of guinea pig and mouse dentin matrix. The rat
also produced a small deposit of cartilage in implants of
human bone. The mouse produced bone in response to
mouse and rat dentin matrix but not to guinea pig dentin
matrix. The guinea pig did not produce bone even in
response to guinea pig dentin. In unpublished experiments,
our research group obtained good yields of bone in
implants of unpowdered guinea pig dentin in guinea pigs.
Consequently, we consider the small particle size, and the
chemical agents used by Huggins, Wiseman, and Reddi
[17] for preparation of the demineralized powder, to be
deleterious to a signiﬁcant part of the morphogenetic
activity in guinea pig dentin matrix. Nevertheless, we agree
with them that allogeneic implants of bone matrix produce
lower yields in the guinea pig than in either the rabbit or
the rat [9].
Implants of ethylenediaminetetracetic acid (EDTA)
demineralized bone matrix have no morphogenetic activity
in guinea pigs and dogs. When the recipient is a rat or
rabbit, species with bone morphogenetic property of high
stability, bone will be produced in allogeneic recipients
only if EDTA is used in low concentrations at neutral pH in
the cold for a brief period of time [4]. Nade [18], for
example, demineralized rabbit bone in EDTA at 4 C, and
produced a matrix with some bone morphogenetic activity,
but much greater activity is obtained if EDTA is avoided
altogether and substituted with dilute HCl or H3PO4 at 2 C.
To appreciate the chemical lability of the BMP, it is nec-
essary to quantitate the reaction, eg, express the yield in
terms either of milligrams of new bone ash per gram of
preimplanted matrix [10, 12] or of alkaline phosphatase
activity per microgram of deoxyribonucleic acid (DNA)
[11, 14].
Nade [18] assumed that a pluripotential mesenchymal
cell is responsible for osteogenesis. This assumption is
difﬁcult to reconcile with the concept of modern embry-
ology, which holds that there are no undifferentiated cells
in postfetal life in mammalian species. Even in the rabbit, a
species with strong determination for osteogenesis in
postfetal life, bone cell differentiation is restricted to spe-
cial populations in limited regions of the body [6, 12, 13].
Mesenchymal cells, like other cells, are competent or
incompetent to respond to the bone morphogenetic matrix,
depending on whether implantation is made in visceral or
somatic organs [6]. Huggins, Wiseman, and Reddi [17]
presented a hypothesis of a ﬁbroblast transforming factor
(FTF). Reminiscent of the old idea of metaplasia of a
ﬁbroblast into a chondroblast or osteoblast, the FTF would
act directly on ambient cells. However, bone cell differ-
entiation, as observed by radio autographic
3H-thymidine
labeling techniques, generally is preceded by a series of
two or more preparatory mitotic divisions [5].
In the FTF hypothesis, the term ﬁbroblast is used
synonymously with the terms mesenchymal cell and
connective tissue stem cell. We reserve the term ﬁbroblast
for a cell differentiated to produce only ﬁbrous connective
tissue, and assume that before a ﬁbroblast can differentiate
into a chondroblast, modulation and mitotic division must
occur to generate chondroblasts and osteoprogenitor cells
or preosteoblasts [21]. Direct transformation of a ﬁbro-
blast (one differentiated cell) into an osteoblast (another
differentiated cell) may be possible, but we have not
observed it in cells labeled with
3H-thymidine in growing
bone in implants of bone matrix [5]. Mitosis does not
diminish the determination of the cells for osteogenesis.
Instead, mitosis is required to assemble new popula-
tions of mesenchymal cells with preexisting osteogenetic
competence for the osteogenetic process [5, 9]. The
preparations of rat bone matrix that will be described
invite immediate ingrowth of mesenchyme [9], promote
transfer of bone morphogenetic activity within 6 days
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1[14], and produce the maximum yield of new bone within
28 days [10].
Materials and Methods
The diaphyseal segment of long bones of 200 adult rats,
Sprague-Dawley strain, were excised, cleaned of all muscle
attachments, and washed until grossly free of bone marrow
cells. The segments of mechanically cleaned cortical bone
were demineralized in 0.6 N HCl at 2 C for two days,
lyophilized, and stored in sterile packages. This preparation
almost invariably produces new bone in quantities of
500 mg of ash per gm of preimplanted mineral-free matrix
30 days after implantation in muscle of allogeneic rats
[10]. Segments of matrix untreated and treated in various
ways to chemically extract or alter the structure of the
protein were implanted for four weeks, and examined by
radiographic, analytical (ash), and histological methods.
ULTRASTRUCTURE.—Three samples of the preparation of
demineralized bone matrix described were prepared for
examination by electron microscopy. Samples less than
1m m
3 in volume were ﬁxed in 3.0% glutaraldehyde buf-
fered with 0.067 Ms -collidine or 0.033 M sodium
cacodylate, and postﬁxed in 1% osmium tetroxide. Each
sample was aligned for examination in longitudinal and
cross sections, dehydrated in solutions of alcohol of
increasing concentrations, transferred to propylene oxide,
impregnated with epoxy resin, and embedded in a curing
agent (Epon). Polymerization was produced by heating at
60 C for 48 hours.
Thick sections were cut with glass knives and stained
with toluidine blue to locate speciﬁc areas of interest with
the light microscope. Thin sections were cut from selected
blocks, and trimmed to less than 1.0 mm
3 in volume.
Staining procedures were used as follows: grids were
ﬂoated on saturated uranyl acetate in aqueous solution for
3.5 minutes, followed by lead citrate for 3.5 minutes for
impregnation of cell organelles and membranes, or exposed
to 5% phosphotungstic acid (PTA) for impregnation of
collagen ﬁbrils of old matrix and cement lines, and/or
stained with 0.5% bismuth nitrate in 0.1 N nitric acid for
precipitation of proteoglycan [22].
ENZYME DIGESTION.—a-Amylase-digested bone matrix.—
Fifty samples of bone matrix, prepared as described, were
transferred to a solution of crystalline amylase (a-amylase
840 U/mg).
1 The solid to solution ratio was 0.1 gm of
matrix to 10 ml of a solution of 35 mg amylase per liter of
0.2 M NaH2PO4 buffer, pH 5.4. Incubation was carried out
for 90 hours at either 2 or 25 C. Digests and matrix
residues were analyzed for hydroxyproline, hexosamines,
amino nitrogen (Ninhydrin), uronic and sialic acids, and
DNA. The matrix residues were washed repeatedly in cold
distilled water for two hours and implanted into muscles of
allogeneic rats.
Trypsin-digested bone matrix.—Fifty samples of rat
bone matrix, demineralized as described, were transferred
to a solution of trypsin (lyophilized trypsin, 180 U/mg),
1
containing 2 mg of enzyme per ml of 0.1 M phosphate
buffer, pH 7.6. The solid to solution ratio of the system was
0.1 gm of lyophilized bone matrix per 25 ml of enzyme-
phosphate buffer solution. Controls for each set of samples
of bone matrix were incubated in equivalent volumes of
phosphate buffer solution without the enzyme. All samples,
control and experimental, were incubated at 15 C, and ﬁve
matrix segments from each group were removed and
washed several times in cold distilled water and implanted
in allogeneic adult rats. Aliquots of the enzyme solution
were tested for activity with casein as a substrate. Matrix
digests and residues were analyzed for hydroxyproline,
hexosamines, amino nitrogen (Ninhydrin), uronic and sialic
acids, and DNA. Space does not permit presentation of the
complete chemical analyses. The biological implications
and interpretations will be reported here.
CALCIUM CHLORIDE EXTRACTIONS OF PROTEOGLYCANS.—Six
segments of the preparations of demineralized cortical bone
describedabovewereextractedfor24 hourswitheachofthe
solutionsofcalciumchloride(CaCl2)listedinTable 1.A6.0
and 0.6 M solution of CaCl2 was used for the extraction of
1m m
3 diced fragments of demineralized cortical bone. Six
segments were implanted in the anterior abdominal muscles
of each recipient and excised after 28 days. Each recipient
received one of each, including a saline control, of the
preparations exposed to successively increasing concentra-
tions of CaCl2 to test the biologic activity of matrix with
variable residual quantities of proteoglycans. The basic
assumption is that the effect of calcium ions is the same on
boneasoncartilage,asdescribedbyTsiganosandMuir[23],
Gregory et al. [24] and Hallen [25].
CHEMICAL MODIFICATION OF THE PROTEINS OF BONE
MATRIX.—Glutaraldehyde cross-linking.—Three segments
of demineralized rat bone matrix were treated in 100 ml of
each of the following aqueous solutions of glutaraldehyde
at 2 C for one hour: 1, 2, 5, 10, 100, 1,000 and 2,000 mM/
liter before implantation.
Formaldehyde cross-linking.—Three segments of
demineralized normal and lathyritic bone matrix were
treated before implantation in 1, 1.8, 2.0, and 3.3 M
solutions of formaldehyde to produce supernumerary
intermolecular and intramolecular crosslinks as denned
by Nold, Kang, and Gross [26].
Remazol black cross-linking.—Three segments of rat
bone matrix were demineralized in 0.6 N HCl containing
1 Worthington Biochemical Corp., Freehold, NJ.
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and implanted in allogeneic host animals.
Borohydride reduction.—In six segments of deminer-
alized bone matrix, the crosslinks were reduced before
implantation in 100 ml of each of the following solutions
of sodium borohydride (NaBH4)[ 28, 29] in carbonate
buffer at pH 7.4: 0.5, 5, and 50 mM/liter.
Dinitrophenylation.—Three segments of rat bone matrix
were exposed before implantation to solutions of l-ﬂuoro-
2,4-di-nitrobenzene (FDNB) [30] of the following con-
centrations: 3, 5, 10, 26, 53, and 268 mM/liter.
Deamination.—Three segments of fresh rat bone were
demineralized and denatured [31] in 0.6 N HNO2 over a
period of three days.
Results
ULTRASTRUCTURE.—When rat bone was demineralized at 2
C in 0.6 N HCl with continuous stirring for not more than
48 hours, and immediately ﬁxed by freeze-drying, the
matrix consisted of a mesh of cross-banded collagen ﬁbrils
suspended in a lacework of noncollagenous constituents.
Except for a small quantity of cell debris, the osteocyte
lacunae and the canaliculi were empty. The collagen ﬁbrils
were well preserved, and arranged in bundles and layers.
The direction of the collagen ﬁbrils, alternating in longi-
tudinal, oblique and transverse planes, produced a
laminated structure. In longitudinal and oblique planes,
electron micrographs of the laminated structure showed no
space between ﬁbrils. In cross sections, however, the
structure was surprisingly different; there were large vol-
umes of space between ﬁbrils, constituting approximately a
third of the matrix domain. These interﬁbrillar spaces were
ﬁlled with a lacework of ﬁne granules resembling electron
microscope (EM) patterns of in vitro and in vivo prepara-
tions of proteoglycans. Although the lacework was
imperfect in some regions, presumably from leaching of
protein, the repeating pattern was constant in all sections
and preparations (Figs. 1–3).
Over a period of two weeks after implantation and
exposure to body ﬂuids and enzymes of the recipient
muscle, the old matrix gradually lost the cross-banded
structure of collagen ﬁbrils and the interﬁbrillar lacelike
conformation of proteoglycans. Although calciﬁcation
occurred as soon as osteoblasts differentiated and new bone
matrix was deposited on the surface of the old matrix, the
bulk of the old bone collagen did not recalcify. The
osteocytes of new bone were enclosed in a thin layer of
Fig. 1 Demineralized cortical bone matrix, lyophilized and super-
ﬁxed with 3% glutaraldehyde and 1.3% osmium tetroxide, cut in
sections approximately 500 A thick and stained with uranyl acetate
and lead citrate. Note large volume of space ﬁlled with interﬁbrillar
electron-dense material, presumably proteoglycans (arrows) in the
area cut in cross section (X). In longitudinal section (L) overlapping
intertwined arrangement of collagen ﬁbril (F) obscures large volume
of interﬁbrillar noncollagenous material in bone matrix.
Table 1. Effect of CaCl2 extraction on bone morphogenesis in
implants of bone matrix four weeks after implantation
Solution mm
3 new bone/
6m m
3 preimplanted
matrix*
mg ash/gm
preimplanted
matrix
0.9% NaCl 5.0 520 ± 51
0.1 M CaCl2 5.0 550 ± 48
0.2 M CaCl2 5.0 495 ± 32
0.6 M CaCl2 5.0 500 ± 58
1.0 M CaCl2 4.5 480 ± 38
2.0 M CaCl2 3.0 325 ± 29
6.0 M CaCl2 2.0 150 ± 12
6.0 M CaCl2 (tissue diced,
1 day in solution)
00
0.6 M CaCl2 (tissue diced,
1 day in solution)
5.0 502 ± 45
0.6 M CaCl2 (tissue diced,
4 days in solution)
4.5 490 ± 42
0.6 M CaCl2 (tissue diced,
9 days in solution)
4.0 395 ± 40
0.6 M CaCl2 (tissue diced,
25 days in solution)
00
* Based on correlated radiographic and quantitative histologic
observations.
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1uncalciﬁed new collagen, but otherwise were completely
enveloped in calciﬁed bone matrix. The earliest deposits of
apatite mineral appeared in clusters, which later coalesced.
High power EM of the ﬁbrils in cross section showed the
microcrystallites formed between and on the surface of the
collagen ﬁbrils. A space of less than 1.0 lm remained
between the plasma membrane and the calciﬁed collagen,
and continued along the extensions of the cell membranes
of osteocytes (Fig. 4). Microﬁlaments ﬁlled the core of
osteocyte extensions.
In glutaraldehyde-perfused implants, the deposits of
mineral in new bone were chieﬂy crystalline. The micro-
crystals were rodlets, 400 9 50 9 50 A (Fig. 5). The new
bone collagen, either in the precalciﬁed or calciﬁed state,
had the same structure as the collagen of the old matrix
before it was implanted and exposed to ﬂuids of the body.
In high power electron micrographs of the matrix cut in
true cross section, there was always a large area, approxi-
mately a third of the space occupied by collagen ﬁbrils,
occupied by interﬁbrillar proteoglycans and ground
substance.
ENZYMATIC DIGESTION OF NONCOLLAGENOUS CONSTITUENTS.—
Segments of bone matrix were treated with a-amylase in a
phosphate buffer solution at 25 C and at 2 C (using buffer
solution without the enzyme for controls), for chemical and
implantation studies. Chemical analysis of the residue
showed that amylase-digested matrix lost 45 lg of hexosa-
mine per gm of dry weight, compared to a loss of 10 lgb y
matrix treated only with the buffer solution for this enzyme
system. Implants of the matrix residues after digestion with
amylase produced almost as much bone as control prepara-
tions (Table 2).
Experiments on samples of bone matrix treated with
trypsin at 15 C for various periods of time before
implantation are summarized in Table 2. This temperature
is below the point of thermal denaturation of collagen but
sufﬁciently high for proteolytic action. Analysis of the
24 hour digest revealed 21.3 lg of hexosamine and
680.8 lmol of amino acids per gm of lyophilized preim-
planted matrix, but no hydroxyproline. After implantation
of matrix residues digested for eight hours, new bone yield
was only 10% of that of the control. In matrix digested for
24, 48, and 96 hours, the yield of new bone was zero.
NEUTRAL SALT-SOLUBLE PROTEINS OF BONE MATRIX.—-
Table 1 summarizes data obtained from experiments with
matrix that was ﬁrst demineralized and then extracted with
solutions of CaCl2 of increasing concentrations before
Fig. 2 Rat demineralized cortical bone matrix, lyophilized and
superﬁxed with 3% glutaraldehyde and 1.3% osmium tetroxide, cut
in sections approximately 500 A thick and stained with bismuth
nitrate 0.5% in 0.1 M nitric acid. Note electron-dense granules of
bismuth-staining material presumably proteoglycans (arrow) between
and on collagen ﬁbrils (F).
Fig. 3 Rat bone matrix superﬁxed with glutaraldehyde and stained
with 5% phosphotungstic acid and bismuth nitrate. Note bismuth-
stained coat on collagen ﬁbrils (arrows) and relatively large volume
of interﬁbrillar space for proteoglycans.
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solution either as uncut diaphyses or 1 mm
3 diced frag-
ments. Chemical extraction of whole diaphyses with 0.1 to
0.6 M CaCl2 for 24 hours did not reduce the yield of new
bone after implantation of the residual matrix in muscle.
Extraction of diced samples with 0.6 M CaCl2 for periods
of two to four days did not reduce the bone morphogenetic
activity of rat bone matrix. However, extraction of diced
samples for a period of nine days reduced the yield to 80%
of controls; extraction for 25 days eliminated all the bone-
forming potential from the residue.
Extraction with 6 M CaCl2 over a period of only
24 hours removed as much bone-forming potential from
whole, uncut segments of matrix as 0.6 M solutions from
diced matrix over long periods of time. With intermediate
concentrations, the yields declined approximately 5% after
extraction with 1 M CaCl2, 40% with 2 M CaCl2, and 70%
with 6 M CaCl2. Diced matrix extracted with 6 M CaCl2
for only 24 hours produced no new bone after implantation
in muscle. The components of the matrix, extracted by
these solutions, were analyzed chemically for hydroxy-
proline and uronic acid. No hydroxyproline was found in
any measurable quantity after any of the extraction pro-
cedures carried out at 2 C. Uronic acid, however, was
extracted by all solutions in the following quantities,
expressed in lmol/gm of lyophilized matrix: 0.6 M CaCl2
extracted 4.2; 2 M CaCl2, 3.6; 6 M CaCl2, 3.5. How much
BMP is unaltered, extracted, precipitated, or denatured by
each concentration of CaCl2 is under investigation.
DENATURED PROTEINS.—Table 3 summarizes observa-
tions on demineralized bone matrix treated with
denaturants with nonspeciﬁc and speciﬁc chemical action
on the molecular conﬁguration of proteins. Glutaraldehyde,
a cross-linking agent, reduced the yield of new bone only
slightly when concentrations of 1 to 5 mM/liter were used;
concentrations of 10 mM/liter reduced the yield by 40%,
and concentrations of 100 mM/liter or above reduced the
yield to zero. Formaldehyde in concentrations of 1 to 2 M
also reduced the yield to zero in 28-day-old implants. In
12-week-old implants of matrix treated with concentrations
of formaldehyde ranging between 1 and 3.3 M, there were
a few small islands of cartilage and occasionally a scanty
deposit of bone. After shorter periods of implantation, eg
four weeks, samples treated with such high concentrations
of formaldehyde contained only ﬁbrous tissue.
Fig. 5 Structure of earliest deposits of mineral in new bone in
another area of implant shown in Fig. 4. MF, osteocyte extension with
microﬁlaments; F, uncalciﬁed cores of collagen ﬁbrils and groups of
ﬁbrils; CC, apatite deposits in spaces between and in surface of
collagen ﬁbrils; UNBC, uncalciﬁed or precalciﬁed new bone matrix.
In cross section, because of interﬁbrillar space, at least a third of
matrix domain is available for occupancy by ground substance
including proteoglycans, shown in Figs. 1 to 3.
Fig. 4 Amorphous structure of old bone matrix after two weeks of
exposure to body ﬂuids and apposition of new bone. OC, osteocyte;
NB, calciﬁed new bone matrix; NC, uncalciﬁed and precalciﬁed new
bone matrix; OM, nonstaining old bone matrix with deposits of
mineral at line of contact with new bone.
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1When demineralized bone matrix was treated with 1%
Remazol black, a vital dye that binds to collagen, to an
interﬁbrillar component, or to both, there is a deleterious
effect on the bone morphogenetic protein. Borohydride, in
concentrations of 0.5 to 50 mM/liter had no effect on the
bone morphogenetic activity of the matrix. FDNB reduced
the yield of new bone in concentrations higher than
10 mM/liter but did not eliminate all morphogenetic
activity until the matrix was exposed to concentrations in
excess of 268 mM/liter. Nitrous and nitric acid, in the same
concentrations and under the same conditions of time and
temperature used for demineralization of bone with HCl,
destroyed all morphogenetic activity.
Discussion
The space occupied by collagen ﬁbrils represents about two
thirds of the total volume of bone matrix. The remaining
third is occupied by interﬁbrillar noncollagenous proteins
and ground substance.
Although 97% of the weight of the dry fat-free demin-
eralized bone is collagen, about 30% of the volume of fresh
bone matrix is occupied by noncollagenous constituents.
Electron micrographs of the matrix cut in cross section
reveal that this 30% contains the remaining 3% of the dry
weight. The same 3% includes large molecules of proteo-
glycans that weigh much less than collagen molecules,
but are spread out over much larger areas of the matrix
domain. The area occupied by proteoglycans is identiﬁed
by bismuth-stained EM sections [22] as a lacework of
small electron-dense granules.
The intertwined and helical weave pattern of the colla-
gen ﬁbers obscures the large volumes of space between the
collagen ﬁbrils. Consequently, the weight relationships
Table 3. Yield of new bone in implants of demineralized matrix
treated with protein denaturants (four weeks after implantation)
Agent mM/liter mg bone ash/
gm preimplanted
matrix
Glutaraldehyde 0 500
1 505
2 510
5 450
10 300
100 0
1000 0
2000 0
Formaldehyde, (4 weeks after
implantation)
1000 0
Formaldehyde, (4 weeks after
implantation)
1800 0
Formaldehyde, (4 weeks after
implantation)
2000 0
Formaldehyde, (12 weeks after
implantation)
3300 10
Formaldehyde-treated lathyritic
matrix (4 weeks after
implantation)
1800 0
Remazol black (1% w/v) 0
Borohydride 0.5 500
5 450
50 490
FDNB 0 490
3 460
5 450
10 470
26 210
53 200
268 20
HNO3 600 0
HNO2 600 0
Table 2. Bone morphogenetic activity of demineralized matrix
treated with enzymes
Treatment of the
preimplanted matrix
mm
3 new bone/6 mm
3
preimplanted
matrix
mg bone ash/
gm preimplanted
matrix
Control (no treatment) 5.0 520 ± 51
a-Amylase in phosphate
buffer, pH 5.4,
at 25 C, 90 hr
5.0 490 ± 40
a-Amylase in phosphate
buffer, pH 5.4,
at 2 C, 90 hr
5.0 500 ± 10
Phosphate buffer
without amylase,
at 25 C, 90 hr
5.0 510 ± 40
Phosphate buffer
without amylase,
at 2 C, 90 hr
5.0 515 ± 20
Trypsin in phosphate
buffer, pH 7.6
at 15 C, 8 hr
0.5 50 ± 5
Trypsin in phosphate
buffer, pH 7.6,
at 15 C, 24 hr
00
Trypsin in phosphate
buffer, pH 7.6,
at 15 C, 48 hr
00
Trypsin in phosphate
buffer, pH 7.6,
at 15 C, 96 hr
00
Phosphate buffer
without trypsin,
at 15 C, 96 hr
0 485 ± 20
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deceiving, and tend to obscure the spatial characteristics of
the matrix that are responsible for its bone morphogenetic
activity.
BONE PROTEOGLYCANS.—Bone morphogenetic activity in
implants of residues of enzymatically digested matrix
indicates that BMP resides in or on quaternary or higher
structures of the collagen ﬁbrils. Alpha-amylase removes
sugars and small quantities of amino acid residues without
altering the 640 A striations on the collagen ﬁbrils or
reducing the bone morphogenetic activity. As a-amylase
removes signiﬁcant quantities of polysaccharide but only
insigniﬁcant quantities of protein [32, 33], its action on
bone matrix suggests that the polysaccharide moiety is not
a part of the BMP.
EDTA mobilizes some of the same components as a-
amylase, but extracts larger quantities of protein, sialo-
protein, proteoglycans, and other interﬁbrillar constituents
[32–34]. In concentrations used for decalciﬁcation of bone
at pH 7.4 at room temperature, EDTA extracts proteogly-
cans but in addition removes or denatures BMP. These
observations point to the protein core of proteoglycans or a
component of the collagen ﬁbril [29, 30, 34] as the locus
of BMP.
TRYPSIN-LABILE PROTEINS OF BONE MATRIX.—The absence
of osteogenetic activity in implants of bone matrix digested
with trypsin at 15 C suggests that either the protein core of
bone proteoglycans or the telopeptide terminal, nonhelical
portion of the collagen molecule, or the link between these
two structures, imposes the bone morphogenetic pattern on
mesenchymal cells. Evidence of enzymatic cleavage of te-
lopeptides of collagen comes from amino acid analyses.
The trypsin-labile region of bone collagen does not include
hydroxyproline, and therefore is different from the trypsin-
resistant triple helical portion of the collagen macromole-
cules [35, 36]. Rubin et al. [35] cleaved the peptides of the
N-terminal region of collagen with pepsin and noted that
hydroxyproline and hydroxylysine were missing and gly-
cine was low, whereas tyrosine, aspartic acid, and glutamic
acid were high. Pepsin also reduced the viscosity of the
solutions of tropocollagen and prevented reconstitution of
the ﬁbrillar form, but the triple helix structure that repre-
sented 95% of the total macromolecule was unaffected.
Bornstein, Kang, and Piez [37] claimed that trypsin is less
speciﬁc than pepsin and may not attack the iV-terminal
region of many preparations of native collagen. The telo-
peptide is a part of the 10% of the length of the collagen
molecule entering into overlap region, and is not detectable
by EM. Davison and Schmitt [36] reviewed evidence for
and against the theory of the terminal peptides of the col-
lagen molecules, and proposed that the extrahelical portion
of the collagen molecule is responsible for immunologic
properties, pathologic disorganization, and aging processes.
Inasmuch as enzymes can act on insoluble bone collagen
to yield amino acids but not hydroxyproline, and insofar as
the residual matrix produces no new bone following
implantation in muscle, it is reasonable to assume that te-
lopeptides of the nonhelical region of the collagen
molecule could be the binding site, the site itself, or a part
of the site of the bone morphogenetic activity. Another
observation to support this assumption comes from
implants of lathyritic bone, which are similarly nonosteo-
genetic [7]. Limited proteolysis of soluble collagens by
pepsin and trypsin produces monomers physicochemically
similar to those obtained from lathyritic collagen [38].
Amino acid analyses now in progress may answer the
question of whether telopeptides of insoluble collagens are
cleaved when BMP is destroyed by the action of limited
proteolysis of bone matrix.
NEUTRAL SALT-SOLUBLE NONCOLLAGENOUS AND COLLAGE-
NOUS COMPONENTS OF BONE MATRIX.—At 2 C, chemical
extraction with solutions of CaCl2, in successively
increasing concentrations, removes signiﬁcant quantities of
uronic acid without solubilizing any of the collagen of bone
matrix. Solutions of 0.5 to 1.0 M CaCl2, which extract 25
to 30% of the polysaccharides from cartilage [23–25, 39],
also extract polysaccharides from bone matrix, but
implants of the residue produce high yields of new bone.
Concentrations of 2 M CaCl2, which remove 80% of the
polysaccharide of cartilage matrix, extract slightly less
polysaccharide than 0.6 M CaCl2, yet reduce the bone
yield by more than 40%. In solutions of 4 M CaCl2, the
crossbanding disappears from the collagen [40], and in
solutions of 6 M CaCl2, the entire structure of collagenous
and noncollagenous matrix is denatured or precipitated.
These solutions eliminate all of the bone morphogenetic
activity. The reduction of bone morphogenetic activity in
neutral salt solutions of high but not low concentrations,
suggests that BMP is associated intimately with proteo-
glycans and the native structure of bone collagen.
BLOCKING AND CROSS-LINKING REAGENTS.—Experiments
with blocking and cross-linking agents suggest that the
BMP becomes nonosteogenetic after dinitrophenylation,
but this adverse effect may reﬂect denaturation as well as
blocking of amino groups of telopeptides. At low concen-
trations, FDNB had slight or no effect, but at
concentrations of 26 mM/liter and greater the yield of new
bone after dinitrophenylation declined precipitously.
Free e-amino groups that react with FDNB also may
react with glutaraldehyde and produce supernumerary
cross-links. Cross-linking with glutaraldehyde forms
intermolecular bonds highly resistant to degradation by
proteolytic enzymes [41]. In concentrations below 5 mM/
liter, glutaraldehyde reduces the yield of bone little or not
at all, whereas in concentrations of 5 to 10 mM/liter, the
reduction is from 10 to 40%. All morphogenetic activity is
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1destroyed by concentrations above 100 mM/liter. Thus,
data obtained from glutaraldehyde cross-linked matrix, like
data obtained from dinitrophenylated matrix, suggest that
the bone morphogenetic activity depends on the undena-
tured native protein structure. The cross-linked structure
alone does not account for bone morphogenesis. Lathyritic
matrix lacking osteogenetic activity [7] did not produce
new bone after cross-linking proteins with formaldehyde
by the method of Veis and Drake [42].
Implants of bone matrix with proteins cross-linked by
high concentrations of formaldehyde retain a low level of
biologic activity, demonstrable only after long periods of
time in muscle. The formaldehyde cross-linked matrix is
resorbed by the proteolytic action of giant cells slowly or
with difﬁculty, but eventually produces small islands of
cartilage and sometimes also scanty deposits of bone. This
observation suggests that the introduction of supplementary
cross-links suppresses but does not destroy all of the bio-
logic activity enclosed in bone matrix.
Remazol black, a cross-linking matrix-seeking vital dye
[43], is a powerful inhibitor of bone morphogenetic activity.
It is not known whether the dye cross-links the terminal
region of the collagen molecule, the whole molecule, or the
noncollagenous proteins. The Remazol black reaction is
important insofar as the dye is selectively bound to an
organic component of calcifying but not noncalcifying
connective tissues. If Remazol black cross-links calciﬁable
collagenous protein and protein polysaccharide complexes,
the dye may constitute a speciﬁc label for BMP.
BOROHYDRIDE STABILIZATION OF INTERMOLECULAR BONDS OF
COLLAGEN.—Reduction with borohydride stabilizes the
intermolecular structure of soluble collagen [28, 44]. The
three dimensional structure of insoluble bone collagen may
be stabilized similarly and made chemically less reactive
than native collagen. Borohydride reduction of bone col-
lagen by means of the procedure of Bailey [28], appears to
stabilize bone collagen without affecting the bone mor-
phogenetic property. How complete borohydride reduction
may be in systems containing insoluble bone collagen and
the BMP presently is not known.
DEAMINATION.—Nitrous acid deamination replaces the
e-amino group of the lysine and hydroxylysine side chains
with a hydroxyl group, without any change in the cross-
banded pattern of the collagen ﬁbrils [31]. Unﬁxed bone
matrix demineralized in either nitrous or nitric acid, under
exactly the same conditions as bone matrix demineralized
in HCl, may be deaminated similarly. Implantation of bone
demineralized by nitrous or nitric acid produced no bone.
Consequently, deamination, like FDNB blocking, suggests
that lysine and hydroxylysine may be a part of the bone
matrix morphogenetic pattern.
PROBLEM OF CHARACTERIZATION OF THE BMP.—The inter-
cellular matrix of hard tissue, composed of molecules of
protein, lipid, carbohydrate, salt, and water, has many
biological and mechanical-functional components intrinsic
to its structure. Nearly all of the protein is structural, but a
small quantity is enzymatic. If it is assumed that a single
molecular species of structural protein is responsible for
bone morphogenesis, the characterization of the BMP and
the determination of its relationship to the collagen, as well
as to other components of calciﬁed tissue, now seems
feasible. This would provide an idea of the way molecules
are put together to produce both bone morphogenetic
activity and calciﬁability of hard tissues.
As noted previously, BMP can be identiﬁed in prepa-
rations of matrix in which proteoglycans may be covalently
bonded to the telopeptide region of the collagen, and part
of a speciﬁc complex protein macromolecule. Such bonds
exist between the protein backbone of proteoglycans and
the collagen, and these are sufﬁciently stable to preserve
the native, three dimensional structure of the matrix even
after the lipids have been extracted and part of the poly-
saccharide has been digested with amylase or extracted
with calcium chloride [4]. Such chemical bonds could
determine the structural characteristics of all of the various
calciﬁed matrixes of specialized tissues such as dentin,
bone, calciﬁed cartilage, enamel, and so forth, and without
any signiﬁcant involvement of such ubiquitous constituents
as sialic acid, hexosamines, phosphoproteins, and phos-
pholipids [45, 46].
There is as yet no clue to the molecular component that
calculable tissues have in common. On the basis of cor-
related observations of systems in vitro and in vivo, we
have postulated a tripartite protein-calcium-phosphate
complex secreted by bone cells along with other compo-
nents of bone matrix [47–49]. The tripartite complex is
formed by the uptake of calcium by carboxylate groups,
followed by a second phase of phosphate ion association
and a third phase of apatite crystal formation within the
folds or interﬁbrillar spaces of the extracellular matrix [49].
Removal of the mineral in the cold prevents thermal
denaturation of the protein, and preserves the bone mor-
phogenetic activity of the previously calciﬁed matrix. The
folded structure of the native calciﬁed proteins can be
visualized as being held together predominately by salt
linkages between charged groups of the protein back-bone
of the proteoglycans. Once deposited in bone matrix,
chemical extraction of polysaccharides, chieﬂy chondroitin
sulfates A and C with 0.6 M CaCl2, or digestion with
amylase, would not alter the folded structure of the BMP.
It is not known whether the integrity of the BMP
requires the helical portion of the collagen molecule or
whether it is self-assembled into a three dimensional
structure by virtue of some of the intrinsic properties of the
BMP molecules themselves. To ﬁnd the answer, it may be
necessary to add the protein backbone of the proteoglycan
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procedure presents the difﬁcult problem of taking the
molecules apart and putting them back together.
There is some reason to believe that the chemical
components of the BMP are not synthesized and deposited
into the extracellular space at the same time and under the
same conditions. For example, some species store BMP in
the matrix in greater quantities and in a more active form
than other species. The rat has comparatively more BMP
than the guinea pig [9, 17]. In subjects with lathyrism,
penicillaminism, rickets, and adrenal hypercorticoidism,
BMP is missing, and therefore not an obligatory part of the
structure of the bone matrix. Thus, we may visualize bone
matrix performing the function of a molecular crate or
framework of collagenous partitions containing BMP and
various accessory chemical components, synthesized in the
course of the long process of cell differentiation, tissue
development, and disease.
Much work must be done before it will be possible to
isolate and deﬁne the BMP in physicochemical terms. For
the present the BMP is considered a highly plastic rather
than static component of the bone matrix. Hopefully, it is
also a constantly renewable component. If the structure of
the intercellular matrix is thought of as a crate for a large
array of substances with different properties and functions,
its size and shape would be determined by specialized
connective tissue cells as well as by macromolecular con-
ﬁgurations. Although the crate is made to hold molecules
of a variety of sizes and shapes, the pigeonholes are not all
ﬁlled at any one time. When ﬁlled with the BMP, cells that
come in contact with the matrix change the pathway of
differentiation and all further tissue development.
The mode of action of the BMP on mesenchymal cells is
not known. Viewed as a ‘‘ﬁbroblast transforming factor’’
postulated by Huggins, Wiseman, and Reddi [17], BMP
could be degraded to promote diffusion through the cyto-
plasm, across the nuclear membrane, and transferred onto a
selection of genes for bone biosynthesis. The BMP mac-
romolecule also may be the substrate for an enzyme in the
plasma membrane permeability is envisioned by Fell [52]
as derived from telopeptides, at the interface between old
matrix and young mesenchymal cells [50, 51]. Before
degradation, the BMP macromolecule may come into
direct contact with the structure of the cell membrane, and
impose a bone morphogenetic change in permeability of
mesenchymal cell membranes; in systems in vitro, a
change in membrane permeability is envisioned by Fell
[52] as the initial step in the process of cell differentiation.
In any event, the disappearance of interﬁbrillar and ﬁbrillar
protein ultrastructure of old matrix, preceding and during
osteogenesis, is circumstantial evidence of transfer of BMP
macromolecules from implant to cell populations with
osteogenetic competence.
Conclusions
Electron micrographs of rat cortical bone, demineralized in
cold diluted HCl within 48 hours to conserve the interﬁ-
brillar structure, reveal that constituents representing 3% of
the dry fat-free weight of the tissue occupy nearly a third of
the matrix domain. These constituents include large mol-
ecules of bismuth nitrate-staining proteoglycans with
attachments to collagen ﬁbrils.
The development of bone and bone marrow in implants
of residues of matrix derived from enzymatic cleavage,
chemical extraction, or organic blocking procedures, sug-
gests bone morphogenetic activity resides in an
interﬁbrillar macromolecular protein complex. Noncollag-
enous proteins of bone matrix or the portions of the
collagen molecules that are digestible with trypsin are
essential for bone morphogenetic activity. Portions of the
proteoglycans cleaved enzymatically with amylase are not
essential for osteogenesis in implants of the residual bone
matrix. Extraction with dilute solutions of calcium chloride
does not remove constituents essential for bone morpho-
genesis; high concentrations of CaCl2, which denature
proteins, destroy bone morphogenetic activity. High con-
centrations of blocking and cross-linking reagents reduce
or eliminate bone morphogenetic activity. Reduction of
bone matrix proteins with borohydride is relatively innoc-
uous, but nitrous acid deamination eliminates all bone
morphogenetic activity. These observations suggest that
the hypothetical bone morphogenetic protein (BMP) is
structurally related either to the telopeptides of the collagen
molecule or to the protein moiety of bone proteoglycans, or
may constitute the bonding site between the two.
The authors thank G. L. Molson for electron
micrographs.
Appendix
INDUCTION: The process of tissue differentiation initiated by
close contact and mutual interaction of cell populations of
diverse origins is called induction. The mechanism pres-
ently is unknown and uncharacterized in physicochemical
terms.
CELL CONTACT: The contact between inducing and
responding cells is mediated by intercellular substances
and is dynamic rather than static in nature.
INDUCER: Diffusible chemical substances of a wide
variety, including inorganic ions, chemical compounds,
vitamins, and hormones capable of stimulating cell dif-
ferentiation in the early stages of embryonic development,
are commonly referred to as primary embryonic inducers.
INDUCTORS: Nondiffusible solid structures, generally
consisting of a complex arrangement of many different
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1substances, leading to differentiation of various tissues and
organs in fetal life are known as inductors [13].
INDUCTIVE MATRIX: The organic framework produced by
demineralization of bones, teeth, and other calciﬁed tissues
serves as an inductive matrix for differentiation of mes-
enchymal cell populations with determination or
competence to develop into cartilage, bone, and bone
marrow.
BONE HISTOGENETIC SUBSTRATUM: The demineralized
organic matrix of enamel is a substratum for differentiation
of mesenchymal cells into bone tissue of a heteromorphic
type resembling that of teleost ﬁshes.
BONE MORPHOGENETIC SUBSTRATUM: The structure of the
demineralized matrix is a substratum for differentiation of
mesenchymal cells, not only into bone as a tissue, but also
bone as an organ consisting of a shell of lamellar bone with
a marrow cavity ﬁlled with hematopoietic bone marrow.
DEMINERALIZED BONE MATRIX: Bone divested of inorganic
salts, with minimal leaching or denaturation of the organic
components of the matrix, is demineralized bone matrix.
Demineralization is carried out in the cold at 2 C, avoiding
protein-polysaccharide extractants such as EDTA. Acids
such as hydrochloric acid, phosphoric acid, or citric acid,
over a period of not more than three to ﬁve days, at con-
centrations of not more than 0.6 N, are preferable. Higher
temperatures, higher concentration, and most organic acids
extract variable quantities of the organic components of
bone matrix and destroy bone morphogenetic proteins. The
highly cross-linked matrix of dentin, although highly per-
meable, protects the BMP against the deleterious actions of
organic acids, high temperatures, and long periods of
exposure.
BONE MORPHOGENETIC PROTEIN (BMP): The osteogenetic
chemical components of the matrix of bone, dentin, and
other hard tissues that are deinsulated by demineralization
and associated intimately with collagen ﬁbrils, are termed
the bone morphogenetic proteins.
BONE INDUCTION PRINCIPLE (BIP): The product of the
interaction of the mesenchymal cells with the surface of the
implanted matrix is referred to as the bone induction
principle (BIP). Since the BIP occupies the space between
the implanted matrix and the extracellular substances
secreted by the mesenchymal cells, it has a three-dimen-
sional structure. The BIP ﬁlls the pores of a millipore
membrane, 125 lm, with a pore size of 0.45 lm[ 3].
TRANSFILTER BONE INDUCTION: The demonstration of
mutual interaction of tissues across a millipore membrane
suggests that the bone induction principle is transmissible.
Inasmuch as smaller pore sizes are ﬁlled with extracellular
substances and ﬁlopodial extensions of plasma membranes,
transﬁlter bone induction cannot be offered as evidence of
action of a diffusible molecular species. Instead, the evi-
dence is more correctly interpreted as extension of a
complex structure intimately related to the surfaces of
interacting cells.
FILOPODIAL EXTENSIONS OF CELL: Tubular extensions of the
plasma membranes of mesenchymal cells, containing
micro ﬁlaments, free of other cell organelles, averaging
about 1 lm in length and 0.3 lm in diameter, are termed
ﬁlopodial extensions. Comparable to ﬁlopods of migratory
ameboid cells, ﬁlopods of mesenchymal cells are contrac-
tile organs that probe the microcanalicular system, vascular
channels, and other intersticies of an implant of bone
matrix [13].
MATRIXCLASTS: The process of multinucleation occurring
by fusion of proliferating mesenchymal cells, produces
matrixclasts. Comparable to osteoclasts, which resorb un-
demineralized bone, matrixclasts are multinucleated cells
having an undulating membrane and are found in excava-
tion chambers in the surfaces of an implant of
demineralized bone matrix [9].
DETERMINATION FOR BONE DEVELOPMENT: Mesenchymal
cells have osteogenetic determination when genes coding
for synthesis of calciﬁable collagenous matrix are present.
Osteogenetic competence or determination is the state of
readiness but not yet activated capacity to differentiate into
bone cells. The basis of osteogenetic competence is a group
of gene-action systems for production of cartilage, bone,
and bone marrow cells. Determination for bone cell spe-
cialization is therefore a heritable or genetic property.
Osteogenetic determination is present in somatic mesen-
chyme, but its expression may be held in abeyance
throughout all of postfetal life. Based on a broad selection
of genes, osteogenetic determination develops in somatic
mesenchyme early in embryonic development, possibly as
early as the gastrula stage [6, 13].
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